A recent observational study suggests that aspirin might be instrumental in preventing flare ups of chronic pulmonary obstructive disease (COPD), thereby improving quality of life for those who suffer from breathing difficulties because of it. Of the 1,700 participants followed in the three-year study, 764 reported that they took aspirin daily. The aspirin users in the 2019 study reported fewer flare ups and less shortness of breath than participants in a control group that did not use aspirin. The COPD patients who took aspirin also did better on the 50-question St. George Respiratory Questionnaire score, which measures quality of life in patients with diseases of airway obstruction. While daily aspirin users reported a lower incidence of flare-ups, the findings need further confirmation, the authors write. “The study demonstrated only a small effect on moderate exacerbations and didn’t indicate that aspirin is as effective as other therapies in reducing exacerbations,” says Amber Lanae Martirosov, PharmD, MSc, BCPS, clinical pharmacy specialist ambulatory care at Henry Ford Health Systems, and clinical assistant professor in the Department of Pharmacy Practice at Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University. “The observational study design also provides some limitations and should be a starting point, not a reason to change clinical practice.” Martirosov urged caution when interpreting the results because ratios tend to overestimate data in research. “Additionally, the study did not provide information about dosing, adherence, or duration of aspirin therapy,” she says. “As such, we are not able to make sound recommendations about aspirin therapy in terms of dosing or duration.”

At Wayne State University, Pharmaceutical Sciences Professor Randall Commissaris and his team are researching marijuana and its effects on driving with a simulator and blood draws from their test subjects to measure nanograms of THC. "We've got .08 for alcohol, is there a number that might be useful for marijuana, because that would be much more helpful for police in terms of enforcement," Commissaris said.

In November, Michigan voted to become the 10th state to approve the use of recreational cannabis. While medical cannabis avails in 23 others. One wonders how many drivers at any given moment have used the substance? In Detroit, scientists are addressing the dearth of knowledge. On the Tuesday before Thanksgiving, Randy Commissaris and Kawthar Alali were in their lab at Wayne State University putting subjects through exercises. Commissaris, associate professor in the department of Pharmaceutical Sciences, and Alali, a graduate student from Saudi Arabia, installed volunteers behind the wheel of a Chevrolet Impala on loan from Doreen Head, director of the school’s occupational therapy program. Pointing at a large screen for fixed-base simulation of real-world driving, the Impala, outfitted with Drive Safety hardware and sensors, translated driver inputs through an interactive program called HyperDrive. The researchers measured performance of a control: a young male whose blood was first drawn and assessed to assure no trace of THC. And the performance of a medical cannabis user: another  young male — the pair were numbers nine and 10 so far in the study — who had consumed the substance within the hour (his cannabis-free baseline was previously established). Each subject spent an hour in the Impala.

Randall Commissaris, associate professor in the Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, talked about highway hypnosis. The phenomenon involves drivers who are aware and paying attention while operating their vehicle, yet, they don’t remember doing it. They’re in a routine while driving and not looking for exits – similar to operating on auto-pilot. Commissaris says one of the biggest potential risks is the challenge of dealing with a surprise situation. Commissaris uses a driving simulator and willing volunteers to study driving at Wayne State University.

At the event hosted by the Wayne State University College of Pharmacy and Health Studies, Christine Rabinak, an associate professor of pharmacy practice at the college, detailed the history of marijuana in the U.S. and the effects and characteristics of different strains. Randall Commissaris, an associate professor at Wayne State, has studied the effects of marijuana on driving ability. He told the audience Tuesday that a "yes" vote on Prop 1 will make Michigan either the ninth or tenth state to legalize recreational pot.

A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.

Henry Ford Health System, Wayne State University, and the Detroit Health Department have teamed up to offer  free immunization fairs in Detroit. As part of the Vaccines For Children program, children who are less than 19 years old, uninsured, underinsured, Medicaid eligible, American Indian or Alaskan Native are eligible to receive the recommended vaccines at no cost. 

Where can you find a history of embalming fluid alongside burial records for some of Detroit’s most famous?